Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Jee Sun Yang
Introduction
Jee Sun Yang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research through his innovative work. His dedication to developing new treatments showcases the potential of scientific advancements in combating serious health issues.
Latest Patents
Jee Sun Yang holds a patent for the use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis. This application relates to a novel benzo-heterocycle derivative and focuses on a composition that comprises these derivatives or pharmaceutically acceptable salts as an active ingredient. The research confirms that KRS has an effect on cancer metastasis by facilitating cancer cell migration through interaction with 67LR. Furthermore, it was discovered that a substance inhibiting the interaction between KRS and 67LR can prevent and treat cancer by inhibiting cancer cell metastasis. This composition provides a novel means for the prevention and treatment of cancer.
Career Highlights
Jee Sun Yang is affiliated with the Medicinal Bioconvergence Research Center, where he continues to explore innovative solutions in medicinal chemistry. His work is characterized by a strong focus on the intersection of chemistry and biology, aiming to develop effective cancer treatments.
Collaborations
He collaborates with notable colleagues such as Sunghoon Kim and Jin Woo Choi, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jee Sun Yang's contributions to cancer research through his innovative patent highlight the importance of scientific inquiry in addressing critical health challenges. His work exemplifies the potential of new treatments to make a significant impact on patient care and outcomes.